The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 116:744-745, February 1960
doi: 10.1176/appi.ajp.116.8.744
© 1960 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by BRAUN, M.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by BRAUN, M.

RESERPINE AS A THERAPEUTIC AGENT IN SCHIZOPHRENIA

MANFRED BRAUN M.D.1

1 The Psychiatry and Neurology service, VA Hospital, Bronx 68, N. Y.

The rapid and dramatic response of schizophrenic patients to treatment with the phenothiazines has resulted in a tendency to discard reserpine as a chemotherapeutic agent in this illness. Our experience suggests that there is a place in the therapeutic armamentarium against schizophrenia for reserpine, particularly in those cases displaying catatonic excitement or stupor with agitation and in those with manic features, especially when these patients fail to respond to the phenothiazines, ECT or insulin coma therapy.







Get information about faster international access.

Privacy Policy

Copyright © 1960 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org